|
4-(6-iodo-1H-indol-3-yl)pyrimidin-2-amine |
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Huggins WM, et al. 2018. ACS Med Chem Lett |
|
5-(5-bromo-1H-indol-3-yl)-1H-imidazol-2-amine |
Depiction based on curated SMILES
NH
2
N
N
H
Br
N
H
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Huggins WM, et al. 2018. ACS Med Chem Lett |
|
5-(6-bromo-1H-indol-3-yl)-1H-imidazol-2-amine |
Depiction based on curated SMILES
Br
N
H
N
N
H
H
2
N
|
Mycobacterium Staphylococcus |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Brackett SM, et al. 2020. RSC Med Chem Huggins WM, et al. 2018. ACS Med Chem Lett |
|
5-methyl-2-phenyl-4-[(2,4,6-tribromophenyl)iminomethyl]-1H-pyrazole-3-thione |
Depiction based on curated SMILES
Br
Br
Br
N
CH
3
HN
N
S
|
Staphylococcus |
Others |
Preclinical (in vitro) |
Suree N, et al. 2009. Bioorg Med Chem |
|
5-methyl-4-{[(4-nitrophenyl)amino]methylene}-2-phenyl-2,4-dihydro-3H-pyrazole-3-thione |
Depiction based on curated SMILES
_
O
O
+
N
N
H
H
3
C
S
N
N
|
Staphylococcus |
Others |
Preclinical (in vitro) |
Suree N, et al. 2009. Bioorg Med Chem |
|
methyl 2-morpholin-4-yl-5-[[(E)-3-thiophen-2-ylprop-2-enyl]amino]benzoate |
Depiction based on curated SMILES
O
N
S
H
3
C
N
H
O
O
|
Staphylococcus |
Others |
Preclinical (in vitro) |
Chenna BC, et al. 2010. Eur J Med Chem |
|
N-benzyl-4-(5-bromo-1H-indol-3-yl)pyrimidin-2-amine |
Depiction based on curated SMILES
Br
HN
N
N
NH
|
Mycobacterium Staphylococcus |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huggins WM, et al. 2018. ACS Med Chem Lett; Zeiler MJ, et al. 2020. ChemMedChem; Brackett SM, et al. 2020. RSC Med Chem
|
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |